Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Duygun AltınSalih TaşkınNedim TokgozogluDogan VatanseverAdbul H GulerMete GungorTolga TasciHasan TuranIlker KahramanogluIbrahim YalcinCetin CelikFaruk KoseFirat OrtacMacit ArvasAli AyhanCagatay TaskiranPublished in: Journal of surgical oncology (2020)
Non-SLN metastasis was more frequent in higher-risk groups and the risk of non-SLN metastasis increased with the size of SLN metastasis. Proceeding to complete lymphadenectomy when SLN is metastatic should further be studied as the effect of leaving metastatic non-SLNs in-situ is not known.
Keyphrases
- sentinel lymph node
- early stage
- endometrial cancer
- lymph node
- neoadjuvant chemotherapy
- squamous cell carcinoma
- small cell lung cancer
- end stage renal disease
- newly diagnosed
- ejection fraction
- palliative care
- chronic kidney disease
- locally advanced
- prognostic factors
- lymph node metastasis
- rectal cancer
- patient reported